KR910002566B1 - 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물 - Google Patents

2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물 Download PDF

Info

Publication number
KR910002566B1
KR910002566B1 KR1019870009863A KR870009863A KR910002566B1 KR 910002566 B1 KR910002566 B1 KR 910002566B1 KR 1019870009863 A KR1019870009863 A KR 1019870009863A KR 870009863 A KR870009863 A KR 870009863A KR 910002566 B1 KR910002566 B1 KR 910002566B1
Authority
KR
South Korea
Prior art keywords
hydrogen atom
compound
atom
hydrogen
formula
Prior art date
Application number
KR1019870009863A
Other languages
English (en)
Korean (ko)
Other versions
KR880003945A (ko
Inventor
후리드리히 아이덴 독토르
페터 지마이너 독토르
왤건 쉬네만 독토르
Original Assignee
마다우스 아크티엔 게젤샤프트
독토르 롤프 마다우스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마다우스 아크티엔 게젤샤프트, 독토르 롤프 마다우스 filed Critical 마다우스 아크티엔 게젤샤프트
Publication of KR880003945A publication Critical patent/KR880003945A/ko
Application granted granted Critical
Publication of KR910002566B1 publication Critical patent/KR910002566B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
KR1019870009863A 1986-09-08 1987-09-07 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물 KR910002566B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863630539 DE3630539A1 (de) 1986-09-08 1986-09-08 Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten
DE3630539.1 1986-09-08

Publications (2)

Publication Number Publication Date
KR880003945A KR880003945A (ko) 1988-05-31
KR910002566B1 true KR910002566B1 (ko) 1991-04-26

Family

ID=6309142

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870009863A KR910002566B1 (ko) 1986-09-08 1987-09-07 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물

Country Status (29)

Country Link
US (1) US4859664A (no)
JP (1) JPS6377882A (no)
KR (1) KR910002566B1 (no)
CN (1) CN1020103C (no)
AR (1) AR243190A1 (no)
AT (1) ATA185987A (no)
AU (1) AU590443B2 (no)
BE (1) BE1002121A4 (no)
CH (1) CH675723A5 (no)
CS (1) CS621687A2 (no)
DD (1) DD275052A1 (no)
DE (1) DE3630539A1 (no)
DK (1) DK464487A (no)
ES (1) ES2013322A6 (no)
FI (1) FI88800C (no)
FR (1) FR2603587B1 (no)
GB (1) GB2194786B (no)
GR (1) GR871209B (no)
HU (1) HU203106B (no)
IL (1) IL83156A (no)
IT (1) IT1228437B (no)
NL (1) NL8701938A (no)
NO (1) NO168530C (no)
PL (1) PL154258B1 (no)
PT (1) PT85656B (no)
SE (1) SE8703343L (no)
SU (1) SU1565346A3 (no)
YU (1) YU46068B (no)
ZA (1) ZA876657B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
US4963547A (en) * 1988-06-01 1990-10-16 Smithkline Beecham Corporation Alpha-andrenergic receptor antagonists and use thereas
NZ229300A (en) * 1988-06-01 1991-04-26 Smithkline Beckman Corp Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
EP0344980A3 (en) * 1988-06-01 1991-05-15 Smithkline Beecham Corporation Alpha-adrenergic receptor antagonists
ATE109483T1 (de) * 1988-06-01 1994-08-15 Smithkline Beecham Corp Alpha-adrenergische rezeptorantagonisten.
DE4102103A1 (de) * 1991-01-25 1992-08-20 Bayer Ag Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5248645A (en) * 1992-09-01 1993-09-28 Phillips Petroleum Company Ethylene oligomerization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124583A (en) * 1964-03-10 Substituted derivatives of
US3118900A (en) * 1962-01-15 1964-01-21 Abbott Lab Substituted derivatives of 3-aza-6, 7-benzo-8-oxa-5-phenylbicyclo[3.3.1]-nonane
US3401166A (en) * 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
US3446820A (en) * 1967-04-03 1969-05-27 Rexall Drug Chemical Substituted benzoxazocines and intermediates
US3869475A (en) * 1973-04-05 1975-03-04 Yissum Res Dev Co 2,6-methano-benzoxacin compounds
JPS50106985A (no) * 1973-05-08 1975-08-22
US4100277A (en) * 1976-11-08 1978-07-11 American Home Products Corporation 4,1-Benzoxazonine derivatives and process therefor
US4315006A (en) * 1979-08-09 1982-02-09 Glaxo Group Limited Benzoxocin derivatives having anxiolytic and anti-convulsant activities

Also Published As

Publication number Publication date
AR243190A1 (es) 1993-07-30
HUT50180A (en) 1989-12-28
AU7816287A (en) 1988-03-10
AU590443B2 (en) 1989-11-02
DE3630539A1 (de) 1988-03-10
JPH0319236B2 (no) 1991-03-14
SU1565346A3 (ru) 1990-05-15
IL83156A0 (en) 1987-12-31
YU46068B (sh) 1992-12-21
PT85656A (en) 1987-10-01
BE1002121A4 (fr) 1990-07-17
GR871209B (en) 1987-11-30
SE8703343L (sv) 1988-03-09
FI88800C (fi) 1993-07-12
GB2194786B (en) 1991-01-02
FR2603587A1 (fr) 1988-03-11
GB2194786A (en) 1988-03-16
HU203106B (en) 1991-05-28
US4859664A (en) 1989-08-22
CN87106267A (zh) 1988-04-13
FI873852A0 (fi) 1987-09-07
NL8701938A (nl) 1988-04-05
NO873727L (no) 1988-03-09
ATA185987A (de) 1994-05-15
CN1020103C (zh) 1993-03-17
FI88800B (fi) 1993-03-31
ES2013322A6 (es) 1990-05-01
SE8703343D0 (sv) 1987-08-28
JPS6377882A (ja) 1988-04-08
IT1228437B (it) 1991-06-17
DK464487A (da) 1988-03-09
ZA876657B (en) 1988-03-08
PL267628A1 (en) 1989-06-12
NO873727D0 (no) 1987-09-07
IT8721436A0 (it) 1987-07-24
FR2603587B1 (fr) 1991-02-01
CS621687A2 (en) 1990-09-12
DD275052A1 (de) 1990-01-10
NO168530C (no) 1992-03-04
DK464487D0 (da) 1987-09-07
KR880003945A (ko) 1988-05-31
PT85656B (pt) 1990-05-31
IL83156A (en) 1992-12-01
CH675723A5 (no) 1990-10-31
FI873852A (fi) 1988-03-09
GB8716668D0 (en) 1987-08-19
NO168530B (no) 1991-11-25
PL154258B1 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
AU654653B2 (en) Therapeutically useful 2-aminotetralin derivatives
EP0170213B1 (en) Glutarimide antianxiety and antihypertensive agents
JPH0570463A (ja) Ｎ−アシル−２，３−ベンゾジアゼピン誘導体、その製造法、それを含有する製剤組成物、およびその製造法
KR20070064437A (ko) 환상 아민 유도체 또는 그의 염
JPH0819065B2 (ja) ベンゾ融合シクロアルカンおよびオキサ‐およびチア‐シクロアルカントランス‐１，２‐ジアミン誘導体
AU2001264116B2 (en) Amidine derivatives as selective antagonists of NMDA receptors
KR910002566B1 (ko) 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물
JPH04338383A (ja) 置換されたベンゾキサゼピン類及びベンゾチアゼピン類
AU2001264116A1 (en) Amidine derivatives as selective antagonists of NMDA receptors
JPS6135175B2 (no)
EP1664017A1 (en) Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
US5376661A (en) 3-aminochroman spiro compounds
EP1572672B1 (en) Benzoxazocines and their use as monoamine-reuptake inhibitors
EP0552386A1 (en) 2-Amino-3 or 6-methoxycyclohexyl amide derivatives
IE902750A1 (en) Coumarin derivatives, their preparation and their use in the¹treatment of cerebrovascular disorders
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
IL90533A (en) History of 5-phenyl-8-nitro-2,3,4,5-tetrahydro-H1- 3-benzazepine, their preparation and pharmaceutical preparations containing them
TW200524875A (en) Benzazepine derivatives as monoamine oxidase B inhibitors
KR930006777B1 (ko) 피리도[1,2-a]인돌 화합물 및 그 제조방법
IL93814A (en) History of benzothiophyranilamines, their preparation and pharmaceutical preparations containing them
AU607354B2 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl) butyl bridged bicyclic imides
AU622506B2 (en) Novel derivatives of 1,7-(imidazo-(1,2-a)pyridine)5'-6'h) ones
JPH0764843B2 (ja) 新規化合物，その製法及びそれを含む医薬組成物
Ong et al. Synthesis and analgetic activity of some 5-aryl-2-azabicyclo [3.2. 1] octanes
KR810001501B1 (ko) 4a-아릴-옥타하이드로-1H-2-피리딘의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee